Page 68 - MEMORIA ANUAL 2020

PROGRAMA ESPAÑOL DE TRATAMIENTOS EN HEMATOLOGÍA (PETHEMA)
MEMORIA ANUAL 2020
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
R, Bargay J, de la Rubia J, Hernández MT, Martínez-López J, Orfao A, Aguirre X, Prósper F, Mateos MV, Lahuerta JJ, Bladé J, San-Miguel JF, Paiva B.
• Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy. Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):e513-e522. doi: 10.1016/j.clml.2020.03.011. PMID: 32336676.
Ribera JM, García O, Chapchap EC, Gil C, González-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martínez-Carballeira D, Mercadal S, Hernández-Rivas JM, Vall-Llovera F, Genescà E, Cladera A, Novo A, Abella E, García-Cadenas I, Monteserín C, Bermúdez A, Piernas S, Montesinos P, López JL, García-Guiñón A, Serrano A, Mar- tínez MP, Olivares M, López A, Serrano J; PETHEMA Group, Spanish Society of Hematology.
• Risk factors and outcome of COVID-19 in patients with hematological malignancies. Exp Hematol Oncol. 2020 Aug 25;9:21. doi: 10.1186/s40164-020-00177-z. PMID: 32864192.
Piñana JL, Martino R, García-García I, Parody R, Morales MD, Benzo G, Gómez-Catalan I, Coll R, De La Fuente I, Luna A, Merchán B, Chinea A, de Miguel D, Serrano A, Pérez C, Díaz C, López JL, Sáez AJ, Bailén R, Zudaire T, Martínez D, Jurado M, Calbacho M, Vázquez L, García-Cadenas I, Fox L, Pimentel AI, Bautista G, Nieto A, Fernández P, Vallejo JC, Solano C, Valero M, Espigado I, Saldaña R, Sisinni L, Ribera JM, Jiménez MJ, Trabazo M, González-Vicent M, Fernández N, Talarn C, Monto- ya MC, Cedillo A, Sureda A; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH).
• The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements.
PLoS One. 2020 Aug 31;15(8):e0237155. doi: 10.1371/journal.pone.0237155. PMID: 32866200.
Cedena MT, Martín-Clavero E, Wong S, Shah N, Bahri N, Alonso R, Bárcenas C, Valeri A, Salazar Tabares J, Sánchez-Pina J, Cuéllar C, Martín T, Wolf J, Lahuerta JJ, Martínez-López J.
• Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
Eur J Haematol. 2020 Aug;105(2):138-47. doi: 10.1111/ejh.13417. PMID: 32243655.
Sitges M, Boluda B, Garrido A, Morgades M, Granada I, Barragán E, Arnán M, Serrano J, Tormo M, Miguel Bergua J, Colorado M, Salamero O, Esteve J, Benavente C, Pérez-Encinas M, Coll R, Martí-Tutusaus JM, Brunet S, Sierra J, Ángel Sanz M, Montesinos P, Ribera JM, Vives S; PETHEMA, CETLAM cooperative groups.
68